ABT · Market closed
$103.69
-0.26% today·exchange $103.69
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
FDA Advisors Said It Should Approve the Grail Multicancer Blood Test
Barrons.com · 8h ago
Is Abbott’s Digital Health Push and Formula Settlement Altering The Investment Case For Abbott (ABT)?
Simply Wall St. · 14h ago
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Zacks · 16h ago
What Makes Abbott Laboratories (ABT) an Attractive Opportunity?
Insider Monkey · 16h ago
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Zacks · 18h ago
Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health
PR Newswire · 20h ago
Headlines from Yahoo Finance. Not investment advice.